Johnson & Johnson ( JNJ ) will begin trading ex-dividend on February 25, 2019. A cash dividend payment of $0.9 per share is scheduled to be paid on March 12, 2019. Shareholders who purchased JNJ prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 4th quarter that JNJ has paid the same dividend.
The previous trading day's last sale of JNJ was $135.42, representing a -9.11% decrease from the 52 week high of $148.99 and a 14.16% increase over the 52 week low of $118.62.
JNJ is a part of the Health Care sector, which includes companies such as Pfizer, Inc. ( PFE ) and Novartis AG ( NVS ). JNJ's current earnings per share, an indicator of a company's profitability, is $5.61. Zacks Investment Research reports JNJ's forecasted earnings growth in 2019 as 4.78%, compared to an industry average of .6%.
Interested in gaining exposure to JNJ through an Exchange Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- iShares U.S. Healthcare ETF ( IYH )
- SPDR Series Trust SPDR SSGA Gender Diversity Index ETF ( SHE )
- RiverFront Dynamic US Flex-Cap ETF ( RFFC )
- iShares U.S. Pharmaceutical ETF ( IHE )
- SPDR Select Sector Fund - Health Care ( XLV ).
The top-performing ETF of this group is XLV with an decrease of -2.83% over the last 100 days. IYH has the highest percent weighting of JNJ at 9.67%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.